BRCA2 and breast carcinoma: A number of large studies, facilitated through the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA), have evaluated associations between genetic polymorphisms and breast cancer risk in BRCA1 and BRCA2 mutation carriers [7-15].